Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Argent Biopharma ( (AU:RGT) ) has shared an announcement.
Argent Biopharma Limited has announced the quotation of 6,250,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of April 23, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially impacting its operations and stakeholder interests positively.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative medical therapies. The company is known for its commitment to advancing healthcare solutions and holds a significant position in the market for its pioneering products.
YTD Price Performance: -20.83%
Average Trading Volume: 554
Technical Sentiment Signal: Buy
Current Market Cap: $6.65M
Find detailed analytics on RGT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue